Clinical Trial Update: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 study evaluating the effects of dopaminergic medications on dopamine transporter imaging in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonian Syndrome

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson Disease, Parkinsonian Syndrome | Phase 2 | Status: COMPLETED